Joining over 50 existing cases, another lawsuit has been filed alleging anti-nausea drug Zofran (ondansetron) was responsible for causing birth defects. The complaint contends that GlaxoSmithKline (“GSK”) marketed Zofran (ondansetron) “off label,” even though it was only approved for use by the FDA for treatment of severe nausea and vomiting in cancer patients or...
Alabama Family Claims Zofran (ondansetron) Caused Heart Defects
Read more
